NRS
AGN

Neville Rodie & Shaw’s Allergan plc AGN Stock Holding History

Neville Rodie & Shaw’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-33,012
Closed -$5.85M – 245
2020
Q1 		$5.85M Hold
33,012
– – 0.71% 48
2019
Q4 		$6.31M Sell
33,012
-5,625
-15% -$1.01M 0.62% 49
2019
Q3 		$6.5M Hold
38,637
– – 0.69% 45
2019
Q2 		$6.47M Sell
38,637
-11,065
-22% -$1.53M 0.68% 47
2019
Q1 		$7.28M Hold
49,702
– – 0.77% 42
2018
Q4 		$6.64M Sell
49,702
-4,900
-9% -$803K 0.81% 40
2018
Q3 		$10.4M Sell
54,602
-2,700
-5% -$496K 1.03% 30
2018
Q2 		$9.55M Buy
57,302
+55,287
+2,744% +$8.88M 1.01% 32
2018
Q1 		$339K Buy
2,015
+46
+2% +$7.72K 0.04% 195
2017
Q4 		$322K Sell
1,969
-830
-30% -$149K 0.03% 200
2017
Q3 		$574K Buy
2,799
+100
+4% +$23.3K 0.06% 155
2017
Q2 		$656K Sell
2,699
-375
-12% -$88.1K 0.07% 153
2017
Q1 		$734K Buy
3,074
+305
+11% +$71K 0.08% 149
2016
Q4 		$581K Sell
2,769
-12,740
-82% -$2.64M 0.07% 159
2016
Q3 		$3.57M Buy
15,509
+170
+1% +$41.5K 0.42% 74
2016
Q2 		$3.54M Sell
15,339
-1,360
-8% -$314K 0.42% 73
2016
Q1 		$4.48M Buy
16,699
+800
+5% +$229K 0.54% 65
2015
Q4 		$4.97M Buy
15,899
+75
+0.5% +$22.3K 0.6% 60
2015
Q3 		$4.3M Sell
15,824
-9
-0.1% -$2.77K 0.53% 61
2015
Q2 		$4.8M Sell
15,833
-330
-2% -$98.4K 0.53% 62
2015
Q1 		$4.81M Buy
16,163
+3,450
+27% +$984K 0.5% 67
2014
Q4 		$3.27M Buy
12,713
+7,010
+123% +$1.75M 0.33% 83
2014
Q3 		$1.38M Buy
+5,703
New +$1.28M 0.14% 117

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Neville Rodie & Shaw's AGN Position: Q2 2020 in Review

Neville Rodie & Shaw sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 33,012 shares — an estimated $5.85M sold.

Neville Rodie & Shaw first reported a position in AGN in Q3 2014 and held it in 23 quarters. The position peaked at $10.4M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Neville Rodie & Shaw reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Neville Rodie & Shaw sold 33,012 Allergan plc shares in Q2 2020, an estimated $5.85M.
  • Neville Rodie & Shaw first reported a position in Allergan plc in Q3 2014 and held it in 23 quarters.
  • Neville Rodie & Shaw's Allergan plc position peaked at $10.4M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Neville Rodie & Shaw's 13F filing for Q2 2020, filed 15 Jul 2020.